logo
Why Isn't My Jock Itch Going Away? What to Do

Why Isn't My Jock Itch Going Away? What to Do

Health Line24-06-2025
Some practices can make jock itch worse or prevent it from healing. But other health conditions may resemble jock itch and require different treatment options.
Jock itch happens when a specific species of fungus builds up on the skin, growing out of control and causing inflammation. It's also called tinea cruris.
Common symptoms of jock itch include:
redness or other color changes
irritation
itchiness that doesn't go away
scaling or dryness
Most cases of jock itch are mild and easily treated.
But there are some activities and 'treatments' that can make jock itch symptoms last longer. Let's dive into what can make jock itch worse, how to tell jock itch apart from other similar conditions, and how to successfully treat jock itch.
What can make the symptoms of jock itch worse?
There are a few things you might do that unintentionally make your jock itch worse. Here are some examples:
Working out. This can cause the infected skin to chafe against nearby skin or clothing and irritate it, making the skin more susceptible to a worsening infection.
Having poor hygiene habits. Using improperly cleaned, damp towels or clothing and not keeping skin dry may promote infection.
Using the wrong treatment. Spreading an anti-itch cream, such as hydrocortisone, on the infected area won't treat the infection. In fact, it can actually worsen it. Steroid medications suppress your immune system, which can increase the area of the infection or make the infection worse.
Having a weakened immune system. Taking immunosuppressants for autoimmune disorders or having a weakened immune system from medication or conditions like HIV can make it harder for your body to fight off fungal infections.
How to tell if jock itch is going away
With early and proper treatment, jock itch should go away within about a month.
Here are some signs that your jock itch is going away:
How to treat severe or resistant groin itching
Got an especially severe or resistant case of groin itching? Here's what you should do if over-the-counter (OTC) topical treatments don't work.
Take antifungal medication
A doctor may prescribe medication for severe jock itch. Here are some of the options:
oral medications like fluconazole (Diflucan)
topicals like clotrimazole (Lotrimin AF), butenafine, or terbinafine (Lamisil)
Use an antifungal shampoo
Medicated shampoos that contain ketoconazole or selenium sulfide are a good, strong treatment for jock itch symptoms. They're available by prescription from your doctor or over the counter.
They don't typically have side effects, and OTC versions are easy to buy at most drugstores.
What if it isn't jock itch?
Some conditions look like jock itch, but they aren't, so they won't respond to typical tinea cruris treatment.
Inverse psoriasis
Inverse psoriasis is a type of psoriasis, an autoimmune condition, that may have a genetic basis.
Like jock itch, it tends to appear in the same areas where you skin chafes, like your groin or inner thighs. Some common treatments for inverse psoriasis include:
prescription topicals
oral medications
biologics
Yeast infection (thrush)
Yeast infections are a similar type of fungal infection caused by the fungus Candida.
They're more common in people with vulvas, but they can also affect the penis from the head and shaft to the scrotum and the nearby groin skin.
Common treatments for yeast infections include:
antifungal topicals like nystatin or clotrimazole (Lotrimin AF)
oral antifungal medications, for more severe cases
Erythrasma
Erythrasma is an itchy, scaly bacterial infection, caused by the bacterium Corynebacterium minutissimum, that often grows in the folds of skin. It is commonly misdiagnosed as jock itch and can lead to severe symptoms like abscesses and fistulas under the skin.
Risk factors for this infection include excessive sweating, humid environments, diabetes, age, and obesity. It is treated with antibiotics like erythromycin or clindamycin.
When to see a doctor
See a doctor if you've used OTC treatments but haven't seen any improvements in your symptoms after 2 weeks.
A doctor may be able to prescribe you a medication that can help, or they can evaluate you for another type of skin disorder that can mimic jock itch.
How to prevent jock itch
Here are some tips for preventing jock itch:
Wash your hands regularly. This is especially important when you touch other people or are about to eat with your hands.
Keep the moist areas of your body clean and dry. This is especially important for areas around your groin and upper thighs.
Bathe at least once a day. Make sure to use gentle, unscented soap and dry off completely before putting clothes on. Bathe more than once a day if you're active or sweat profusely throughout the day.
Don't wear tight clothing. It can trap moisture and cause skin to chafe.
Wear loose-fitting cotton underwear. It'll let your groin and thighs ventilate, especially if you live in a humid climate.
Wash your workout clothes or any equipment your body touches after a sweaty workout.
Have athlete's foot? Don't use the same towel on your feet and other areas of your body. Athlete's foot and jock itch are both caused by tinea fungi and can spread to one another. Treating athlete's foot is important for preventing jock itch.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Herbalife Launches MultiBurn™: A Science-Backed Weight Loss Supplement Supporting Metabolic Health
Herbalife Launches MultiBurn™: A Science-Backed Weight Loss Supplement Supporting Metabolic Health

Yahoo

time31 minutes ago

  • Yahoo

Herbalife Launches MultiBurn™: A Science-Backed Weight Loss Supplement Supporting Metabolic Health

New daily supplement features clinically studied botanicals to support weight loss, healthy fat reduction and energy expenditure* LOS ANGELES, July 07, 2025--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced the launch of MultiBurn™ — a next-generation multi-action dietary supplement designed with clinically studied botanical extracts to support key areas of metabolic health*. Formulated by Herbalife's global team of scientists and nutrition experts, MultiBurn™ is gluten-free, suitable for vegans and made without synthetic colors or dyes, reflecting the company's commitment to clean-label, user-friendly wellness solutions. As consumers continue to seek weight loss solutions, Herbalife offers an innovative, non-pharmaceutical approach with MultiBurn™, a product grounded in science-backed ingredients and a continued commitment to wellness innovation. Built on a foundation of clinical research, MultiBurn™ features a powerful blend of three botanical ingredients: Morosil™ (from Moro blood oranges): supports overall weight loss, including reduced hip and waist circumference and a healthy BMI ‡*. Metabolaid® (hibiscus and lemon verbena extract): helps with healthy reduction of fat and increased feeling of fullness after meals ‡*. Capsifen™ (red chili pepper and fenugreek blend): supports healthy energy expenditure*. MultiBurn™ also contains supporting functional ingredients, including caffeine to stimulate metabolism and provide a feeling of energy and alertness*, and chromium to aid in maintaining blood sugar levels already within the normal range*. "MultiBurn™ was developed using scientific insight into the underlying mechanisms of metabolic health and the challenging cycle of weight gain," said John Heiss, Ph.D., vice president of Global Product Innovation at Herbalife. "Our team carefully selected and combined ingredients based on their botanical profiles and the findings within published, human randomized controlled clinical studies to create an evidence-based solution for weight loss and healthy fat loss*." MultiBurn™ is designed for daily use as part of a balanced healthy lifestyle, with three capsules taken once a day alongside breakfast or lunch. While its ingredients have been shown to be effective individually, MultiBurn™ is recommended to be paired with consistent healthy habits, including a nutritious diet and regular physical activity. It can also be integrated into a broader Herbalife routine, complementing products such as high-protein shakes, fiber supplements and targeted wellness solutions — all supported by Herbalife's global community of Independent Distributors who provide personalized guidance to millions of customers to achieve their weight loss and wellness goals. "Maintaining metabolic health is central to overall wellness and effective weight loss," said Dr. Luigi Gratton, vice president of Health & Wellness at Herbalife. "It supports how the body converts food into energy, regulates hormones and blood sugar, and influences brain function, sleep and mood. Sustainable results come from balanced nutrition, regular physical activity and quality rest, with targeted supplementation like MultiBurn™ providing additional support to help individuals achieve their long-term health goals." For 45 years, Herbalife has been committed to personalized nutrition and science-backed wellness. The company's very first product, Formula 1 Healthy Meal Nutritional Shake Mix, revolutionized meal replacement nutrition and is the #1 protein shake in the world1 — sold in over 90 countries and trusted by millions. Recognized as the #1 active and lifestyle nutrition brand in the world2, Herbalife offers an extensive portfolio of products designed to support healthy weight management, sports performance, daily nutrition and promote skin and body care to help individuals at every stage of their wellness journey. MultiBurn™ builds on this legacy as part of Herbalife's ongoing evolution, bringing together clinical research, ingredient transparency and innovative formulation to address the modern consumer demand for whole-person wellness. MultiBurn™ is now available in the United States, and will be launching in Puerto Rico in September 2025. For more information on MultiBurn™, please click here. Herbalife products are available exclusively through Herbalife Independent Distributors. To purchase Herbalife's MultiBurn™ in the United States or Puerto Rico, consumers can call 1-888-443-7225. For specific questions about using Herbalife products with other weight-loss therapies, contact Herbalife's dedicated team of health and safety professionals at GCS@ * These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. ‡ In combination with a healthy diet and active lifestyle. Morosil™ is a trademark owned by Bionap Srl Metabolaid® is a registered trademark of Monteloeder, S.L Capsifen™ is a trademark of Akay USA, LLC, an Oterra company (1) Source: Euromonitor; CH2025ed, protein shake as sports protein powder, sports protein RTDs, meal replacement, supplement nutrition drinks & protein supplements; combined % RSP share GBO for 2024. (2) Source: Euromonitor; CH2025ed, active & lifestyle nutrition as weight management & wellbeing, sports nutrition and vitamins & dietary supplements definitions; combined % RSP share GBO for 2024. RTD = Ready to Drink; RSP = Retail Selling Price; GBO = Global Brand Owner About Herbalife (NYSE: HLF) is a premier health and wellness company, community and platform that has been changing people's lives with great nutrition products and a business opportunity for its Independent Distributors since 1980. The Company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life. For more information, visit View source version on Contacts Media Contact: media@

US FDA approves KalVista Pharma's swelling disorder drug, shares rise
US FDA approves KalVista Pharma's swelling disorder drug, shares rise

Yahoo

time39 minutes ago

  • Yahoo

US FDA approves KalVista Pharma's swelling disorder drug, shares rise

By Puyaan Singh (Reuters) -KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its shares up more than 17% in premarket trading. The regulator's decision follows an extended review of the drug last month due to heavy workloads and limited resources. Ekterly, which offers a convenient alternative to injectable treatments, will be launched immediately, the company said. KalVista CEO Ben Palleiko said patients find it 'really burdensome' to carry injectable treatments, which are 'almost twice the size of an iPhone,' while Ekterly is packaged 'in a little cardboard wallet, about the size of a credit card.' Other on-demand treatments for hereditary angioedema, which affects about 8,000 people in the United States, include CSL's Berinert, Takeda's Cinryze, and Pharming's Ruconest, which are administered intravenously, as well as injectables such as Takeda's Kalbitor and Firazyr. Needham analyst Serge Belanger said KalVista previously indicated it would likely price Ekterly at a slight premium to Firazyr, the most commonly used on-demand treatment, which costs $11,000 per unit. The life-threatening condition causes sudden, dangerous swelling in the body, including the skin, digestive tract and upper respiratory system, due to deficiency in a protein known as C1 inhibitor. Citizens Bank analyst Jonathan Wolleben estimates peak U.S. sales of Ekterly at around $250 million, adding the early launch could exceed expectations due to potential premium pricing and rapid adoption. Approval of the drug was based on a trial in which Ekterly achieved the beginning of symptom relief in 1.6 hours, while a later trial showed the drug could treat attacks in 10 minutes, the company said. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

June Jobs Data Puts Focus on Healthcare ETFs & Stocks
June Jobs Data Puts Focus on Healthcare ETFs & Stocks

Yahoo

time39 minutes ago

  • Yahoo

June Jobs Data Puts Focus on Healthcare ETFs & Stocks

Nonfarm payrolls in the United States rose by 147,000 in June 2025, following an upwardly revised 144,000 in May and surpassing forecasts of 110,000. The reading was also in line with the average monthly gain of 146K over the prior 12 months. The U.S. unemployment rate edged down to 4.1% in June 2025 from 4.2% in May, defying market expectations of a rise to 4.3%. The rate has held within a narrow 4.0-4.2% band since May 2024, signaling broad labor market stability. The number of unemployed dropped by 222,000 to 7.015 million, while employment rose modestly by 93,000 to 163.366 million. However, the overall labor force shrank by 130,000 to 170.380 million. Average hourly earnings for all employees on private nonfarm payrolls rose by 8 cents, or 0.2%, to $36.30 in June. Over the past 12 months, average hourly earnings increased by 3.7%. In June, average hourly earnings of private-sector production and nonsupervisory employees rose by 9 cents, or 0.3%, to $31.24. Below, we have highlighted the sector and its related exchange-traded funds (ETFs) that will likely experience smooth trading in the days ahead in light of the June jobs data. Healthcare Healthcare added 39,000 jobs in June, similar to the average monthly gain of 43,000 over the prior 12 months. In June, job gains were noted in hospitals (+16,000) and in nursing and residential care facilities (+14,000). Health Care Select Sector SPDR ETF XLV can be played to tap the moderate momentum, although Trump's tax bill may lead millions of Americans to lose healthcare coverage. The fund has 30% exposure to the pharma industry, followed by 22.32% exposure to the healthcare providers & services industry, about 22% focus on Health Care Equipment & Supplies, 17.1% focus on the biotech sector and 8.7% focus on the life sciences tools & services. iShares U.S. Healthcare Providers ETF IHF concentrates on companies in the healthcare provider and services sector. The underlying Dow Jones U.S. Select HealthCare Providers Index is a free-float adjusted market capitalization-weighted index. It measures the performance of the healthcare providers sub-sector of the U.S. equity market. It includes health maintenance organizations, hospitals, clinics, dentists, opticians, nursing homes, rehabilitation & retirement centres. The fund charges 40 bps in fees. Vanguard Health Care ETF VHT tracks the MSCI US Investable Market Health Care 25/50 Index made up of stocks of U.S. companies in the healthcare sector. The fund charges 9 bps in fees and sports a Zacks Rank #1. HCA Healthcare HCA, which has a Zacks Rank #3 (Hold), deserves a mention. It is the largest non-governmental operator of acute care hospitals in the United States. The company has a trailing four-quarter earnings surprise of 7.06%, on average. Welltower WELL is a real estate investment trust (REIT) that is engaged in investments with seniors housing operators, post-acute providers and health systems. The company has a trailing four-quarter earnings surprise of 4.24%, on average. Zacks Rank #2 Omega Healthcare Investors OHI is a self-administered real estate investment trust (REIT), investing in income-producing healthcare facilities, principally long-term care facilities located in the United States and the United Kingdom. The company has a trailing four-quarter earnings surprise of 2.13%, on average. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Omega Healthcare Investors, Inc. (OHI) : Free Stock Analysis Report HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report Health Care Select Sector SPDR ETF (XLV): ETF Research Reports Vanguard Health Care ETF (VHT): ETF Research Reports iShares U.S. Healthcare Providers ETF (IHF): ETF Research Reports Welltower Inc. (WELL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Inicia sesión para acceder a tu portafolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store